2nd EJP RD Joint Transnational Call for Rare Diseases Research Project (JTC 2020)

Basic Information

The ERA-Net E-Rare has successfully implemented ten Joint Transnational Calls for rare disease research projects since 2006. This effort continues in the framework of the European Joint Programme on Rare Diseases (EJP RD) that has been established to further help in coordinating the research efforts of European, Associated and non-European countries in the field of rare diseases and implement the objectives of the International Rare Disease Research Consortium (IRDiRC).

Network

EJP RD

Website

http://www.ejprarediseases.org/index.php/open-call-jtc2020/

Aim of the joint call

The aim of the call is to enable scientists in different countries to build an effective collaboration on a common interdisciplinary research project based on complementarities and sharing of expertise, with a clear future benefit for patients.

Type of joint call

Two Stages - Call with pre-proposals and full proposals submissions

Events

-                                                Launch date
+/12/2019
-                                                Deadline Pre-Proposal
+/02/2020 Submitted proposal: 173
-                                                Deadline Full-Proposal
+/06/2020 Submitted proposal: 30
-                                                Evaluation End Date
+/11/2020
                                                Successful proposal: 18
                                                Proposals funded: 18

Is call co-funded?

Call follow up funding

n/a

Call reasons

n/a

Research fields

Health

Type of research

n/a

Target groups

n/a

Participating networks

n/a

Organisations Participating

Show on map

Country	Organisation
Austria	Austrian Science Fund (FWF)
Belgium	National Fund for Scientific Research (FNRS)
Belgium	Research Foundation Flanders (FWO)
Canada	Canadian Institutes of Health Research (CIHR)
Canada	Quebec Research Fund - Health (FRQS)
Czech Republic	Ministry of Education Youth and Sports (MEYS-MSMT)
Finland	Academy of Finland (AKA)
France	French Foundation for Rare Diseases (FFRD)
France	National Institute of Health and Medical Research (INSERM)
France	National Research Agency (ANR)
Germany	Federal Ministry of Education and Research (BMBF)
Germany	German Research Foundation (DFG)
Greece	General Secretariat for Research and Technology (GSRT)
Hungary	National Research, Development and Innovation Office (NKFIH)
Ireland	Health Research Board (HRB)
Israel	Ministry of Health (CSO-MOH)
Italy	Lombardy Foundation for Biomedical Research (FRRB)
Italy	Ministry of Education, University and Research (MIUR)
Italy	Ministry of Health (MOH/MDS)
Italy	Tuscany Region (TOS)
Lithuania	Research Council of Lithuania (LSC/LMT/RCL)
Luxembourg	National Fund for Research (FNR)
Netherlands	The Netherlands Organisation for Health Research and Development (ZonMw)
Poland	National Centre for Research and Development (NCBiR)
Portugal	Foundation for Science and Technology (FCT)
Slovakia	Slovak Academy of Science (SAS/SAV)
Spain	Institute of Health Carlos III (ISCIII)
Sweden	Swedish Research Council (VR/SRC)
Switzerland	Swiss National Science Foundation (SNSF/SNF)
Turkey	The Scientific and Technological Research Council of Turkey (TUBITAK)

Funded Projects

Acronym	Title	No. partners
AAK-INSIGHT	Aniridia – Novel therapeutic tools to treat or prevent pro...	8
ARMED	Antioxidant treatment as a novel therapeutic option for micr...	5
CHARLIE	CHAnging Rare disorders of LysInE metabolism	11
CureMILS	A reprogramming-based strategy for drug repositioning in pat...	17
DBAGenCure	Lentiviral-mediated gene therapy for Diamond Blackfan Anemi...	10
EpiThe4FSHD	Safety and efficacy of a possible epigenetic therapy for FSH...	9
FANEDIT	Gene editing as a novel therapeutic strategy in Fanconi anem...	8
GET-READY	Genetic therapy for EYS- and USH2A-associated retinal disease	13
MECPer-3D	Personalized MECP2 gene therapy using CRISPR/Cas9 technology...	6
ProDGNE	Novel therapeutic approaches to target GNE Myopathy	6
SCN1A-up!	Therapeutic strategies for Dravet syndrome: upregulation of ...	11
SILENCELQTS	SGK1 inhibition as a novel therapeutic approach in Long QT s...	5
TC NER	Transcription stress Counteracted by Nutritional interventio...	7
TREAT-ARCA	Designing a toolbox of paradigmatic treatments for a targete...	10
TREAT-SGS	Development and preclinical testing in human cell models and...	10
TREATKCNQ	Targeted treatment for KCNQ related encephalopathies: retiga...	6
TreatRP	Translating cGMP analogues into a treatment for retinitis pi...	11
WilsonMed	Multimolecular targeting of copper overload in Wilson disease	11